$PATH

UiPath Just Sank 17%. Is the Stock a Buy on the Dip?

UiPath (PATH) shares fell 17% despite strong Q2 results and raised full-year guidance. Revenue grew 13% YoY to $410M, ARR rose 12% to $1.94B. The company is transitioning to AI integration, with 18 of 20 largest deals including AI components. It forecasts Q3 revenue of $440M-$445M and raised FY revenue guidance to $1.789B-$1.794B.

Original reporting
Published Sep 7, 2026, 1:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 7, 2026, 1:18 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
UiPath Just Sank 17%. Is the Stock a Buy on the Dip? — source image
Decision brief

The 30-second read

$PATHBearishMed
01

Why it matters

The earnings release provides fresh guidance and ARR metrics, offering traders new data to reassess valuation.

02

Market read

First‑report earnings with guidance lift; significant for traders tracking AI‑enabled automation stocks.

03

What to watch

Increasing AI component in deals and high net retention suggest long‑term upside not reflected in the price.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

UiPath is transitioning from pure RPA to an AI‑orchestrated automation platform, aiming to capture higher‑margin AI opportunities.

Company-level read

Ticker impact

$PATHBearishMedium confidence
Context

UiPath reported Q2 results, raised full-year revenue guidance and forecast Q3 revenue, causing a 17% stock drop.

Expected impact

Potential short‑term rebound if price stabilises around the forward‑sales multiple, but downside risk remains if growth slows.

Evidence & confidence

Guidance lift is limited relative to prior expectations; valuation appears stretched despite cash balance.

Market effects

RPA/AI automation sector may see heightened scrutiny on growth forecasts.

U.S. tech stocks could face slight pressure as UiPath's dip influences sentiment.

Limited; primarily affects investors focused on automation and AI software.

Counterpoint

The stock may be oversold; cash runway and ARR growth could support a bounce.

Key entities

  • UiPath

    Robotic process automation firm shifting to AI orchestration.

Related articles

$NVDAHighAI 8/10

Consumer Tech (Aug 31-Sep 4): NVIDIA Buys World's Largest Open AI Developer, Trump Claims Total Control On Hormuz & More

NVIDIA (NVDA) agreed to acquire Hugging Face for $12.93B. Ambarella (AMBA), Asana (ASAN), Samsara (IOT), and others reported earnings beats. Dell (DELL) and Salesforce (CRM) saw strong AI-driven demand. NIO (NIO) missed revenue estimates. TSMC (TSM) raised chip equipment spending. Meta (META) opposed AI regulation. Broadcom (AVGO) and Microsoft (MSFT) expanded AI chip and reporting initiatives.

$PATHMedAI 8/10

UiPath Inc. Q2 2027 Earnings Call Summary

UiPath reported Q2 2027 earnings, highlighting platform evolution, AI integration, and strategic leadership changes. The company achieved GAAP profitability for the fourth consecutive quarter, with a 42% YoY reduction in stock-based compensation. Management expects coding agents to reduce implementation effort by 60% and anticipates FX headwinds of $18M in H2. Net retention rates are stabilizing, and the company is shifting to transaction-based pricing models. UiPath also announced a new develop

$PATHMedAI 8/10

Why UiPath Rallied in August

UiPath (PATH) shares surged 46.3% in August, despite no specific financial news, as analysts grew optimistic about the enterprise software sector. The rally was driven by resilient earnings from peers and raised price targets. UiPath reported Q2 revenue of $410.2M, up 13.3%, but shares fell 16.6% post-earnings due to flat EPS. The company trades at a low valuation with significant cash reserves.

$PATHMedAI 8/10

UiPath Stock Falls 17%; Its $13 Million Guide Raise Adds Just $0.2 Million to the Second Half

UiPath Inc. (NYSE: PATH) shares fell 16.63% to $15.19 despite beating quarterly revenue forecasts. The company raised its full-year revenue guidance by $13 million, but only $0.244 million is incremental for the second half. Q2 revenue was $410.256 million, up 13.4% YoY, with GAAP operating income of $31.6 million. Net new ARR declined to $37 million from $49 million in Q1. Analysts' average price target is $16.37, slightly above the current share price.

$PATHHighAI 8/10

UiPath Q2 Earnings Call Highlights

UiPath reported Q2 revenue growth of 16% (normalized for FX), with cloud ARR exceeding $1.3B. AI-driven platform adoption led to larger customer expansions, including deals with a global insurer, the DoD, and a top Canadian bank. The company saw 109% net retention and forecasted Q3 revenue of $440M-$445M. UiPath also announced leadership changes and plans to detail its long-term strategy at an Investor Day.

$PATHMed

Why UiPath Stock Plunged Today

UiPath (NYSE: PATH) shares fell after its Q2 fiscal 2027 earnings, despite revenue growth of 13% to $410M and adjusted operating income up 43% to $89M. CEO Daniel Dines highlighted the company's strategy of using AI where it adds value. Analyst Kingsley Crane downgraded the stock to 'hold', citing competitive threats from AI-powered rivals like Salesforce.